INmune Bio Inc
Ownership
Ownership Structure
Who owns INmune Bio Inc (INMB)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 84.0% of the shares are freely tradable; institutional investors hold 19.7%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Capital Management, LLC | 2.55 | 706,424 | +2.8 | 06/30/2026 |
| AQR Capital Management LLC | 2.39 | 662,218 | +145.0 | 06/30/2026 |
| BlackRock Inc | 1.12 | 311,613 | -73.9 | 06/30/2026 |
| Geode Capital Management, LLC | 0.69 | 190,215 | -61.6 | 06/30/2026 |
| The Goldman Sachs Group Inc | 0.67 | 185,245 | -20.0 | 06/30/2026 |
| Millennium Management LLC | 0.57 | 159,559 | +0.0 | 06/30/2026 |
| Susquehanna International Group, LLP | 0.57 | 158,452 | -18.5 | 06/30/2026 |
| Jane Street Group LLC | 0.48 | 134,232 | +163.5 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 1.77 | 490,268 | +0.0 | 09/30/2026 |
| Fidelity Extended Market Index | 0.61 | 170,298 | -10.2 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.